Bearded Dragon Respiratory Infections: Workup and Treatment

PublishedMay 2, 2026Reading time7 minExoticRx Editorial

Editorially reviewed against primary literature. Awaiting credentialed clinical reviewer — our editorial process.

A bearded dragon presenting with open-mouth breathing, mucus in the oropharynx, or gaping after exertion is the most common reptile respiratory case in pet practice — and one of the most consistently misdiagnosed. The reflex to "start ceftazidime and see how we go" addresses the bacterial component of a problem that is, on the underlying picture, almost always a husbandry-driven case where the bacterial proliferation is downstream. Treating the bacterial picture without addressing the husbandry root cause produces relapse within weeks.

This article walks through the workup, the husbandry checklist that should anchor every treatment plan, and the published antibiotic principles for the genuine bacterial component.

For drug-specific dose ranges, follow any drug name to its drug page on ExoticRx — every entry carries an explicit evidence level alongside the per-kg numbers.

What "respiratory infection" actually means in a bearded dragon

A bearded dragon's respiratory tract is structurally simple — glottis, trachea, primitive lungs without true bronchial tree subdivision — and the clinical syndrome that gets labelled as "URTI" is most often a combination of:

• Stomatitis or rhinitis with secondary lower respiratory involvement.
• Pneumonia — bacterial, sometimes fungal, occasionally parasitic.
• Mechanical respiratory compromise — coelomic mass effect (egg-laying, fat-pad excess, neoplasia), pleural / coelomic effusion, foreign body aspiration.
• Pseudo-respiratory presentation of cardiac disease, severe anaemia, or pain causing hyperventilation.

A workup that addresses only the first of these will routinely miss cases where the bird's primary problem is mechanical or systemic. Imaging — radiograph, ideally CT — is the first move in any case where the picture is not a textbook upper-respiratory pattern.

The husbandry checklist

Eight points anchor the husbandry review. Skipping any of them is the most common reason apparently-treated cases recur:

1. POTZ availability. Basking spot in the 38–43 °C range, cooler retreat in the 24–28 °C range, accurate measurement at the basking-spot surface (not the air temperature 30 cm above it). A bearded dragon that cannot reach its preferred temperature is metabolically suppressed and immunologically compromised; no antibiotic will fix this.
2. UV-B provision. Adequate UV-B is essential for vitamin D3 synthesis and overall health; chronic deficits weaken every immune system the patient has. Confirm the bulb is appropriate (T5 high-output tubes are now the standard) and that it is replaced on the manufacturer's schedule, not waited out until visible failure.
3. Humidity. Bearded dragons want low ambient humidity (30–40%) most of the time, with localised humid retreats. Excessive humidity is a major contributor to respiratory disease.
4. Substrate. Dusty particulate substrates (fine sand, calcium sand, walnut shells) are recurring contributors to respiratory irritation and aspiration. Tile, paper, or appropriate bioactive substrates are preferred.
5. Ventilation. A poorly ventilated enclosure traps moisture and CO2; respiratory disease is over-represented in enclosures with insufficient cross-flow.
6. Diet. Vitamin A status is increasingly recognised as a contributor to respiratory epithelial health in reptiles. A diet with appropriate dark leafy greens and a balanced supplement regime is part of the medical plan.
7. Stress. Recent re-housing, cohabitation conflicts (multi-dragon enclosures are problematic for many reasons), or environmental disturbance reduce immune competence.
8. Hydration. Many bearded dragons in private collections are subclinically dehydrated; bathing, dietary moisture, and water provision matter clinically.

A patient going home to the same environment that caused the disease is a patient who will return.

Diagnostic workup

The published reptile respiratory disease workup combines:

• Detailed husbandry history — see above; this is the single most informative diagnostic step in many cases.
• Physical examination — auscultation is of limited use in reptiles (no diaphragm, no lobar lung architecture); transillumination of the oropharynx, examination of mucous membranes, palpation for coelomic mass effect.
• Radiographs — DV and lateral. Pulmonary opacification, coelomic effusion, mass effect, GI dilation. Often reveals findings that change management.
• CBC and biochemistry — heteropenia is a non-specific marker of inflammation; biochemistry useful for excluding renal / hepatic concurrent disease.
• Tracheal / glottal lavage with cytology and culture — the central directly-pathogen-identifying test for lower respiratory disease. Both bacterial culture and fungal screening are appropriate; gram-negative pathogens (Pseudomonas, Aeromonas, Enterobacteriaceae) dominate.
• CT imaging where available — substantially more sensitive for focal pulmonary lesions than plain radiographs.
• Faecal parasitology — for completeness; some pulmonary parasites manifest as respiratory disease.

Antibiotic selection

Empiric antibiotic therapy in unstable patients pending culture is reasonable; revising to a culture-driven choice as soon as data return is essential. The typical reptile gram-negative profile drives the choice:

• Ceftazidime — third-generation cephalosporin with strong Pseudomonas coverage. The published intervals in reptiles are species-specific; consult the species-specific dose page rather than extrapolating from canine values. Cranial-half administration to avoid renal portal first-pass.
• Amikacin — broad gram-negative aminoglycoside reserved for severe disease. Pre-treatment hydration mandatory, q48–72h intervals are typical in reptiles, never administer in the caudal half of the body.
• Enrofloxacin — fluoroquinolone alternative; rotate IM injection sites carefully because of sterile abscess risk on repeated dosing.
• Marbofloxacin / Ciprofloxacin — alternative fluoroquinolones.
• Azithromycin — useful where intracellular coverage is needed (atypical or Mycoplasma-associated respiratory disease); reptile intervals tend to q48–72h.

For fungal involvement (less common but recurring):

• Itraconazole or Voriconazole — see the avian aspergillosis article for the broader principles; reptile fungal respiratory disease applies similar drug-selection logic.

Adjunctive therapy

The supporting interventions often outweigh the antibiotic in clinical impact:

• Acetylcysteine — nebulised mucolytic; a useful adjunct in patients with significant mucus or oropharyngeal exudate.
• Hydration — subcutaneous, intracoelomic, or via the ventral coccygeal vein for IV access. Many cases improve substantially with hydration alone.
• Thermal optimisation — the patient must be at the upper end of its POTZ for therapy to work as expected.
• Nutritional support — assist-feeding via syringe of an appropriate critical-care diet for animals with sustained anorexia.
• Multimodal analgesia — Meloxicam for inflammatory pain (with hydration and renal status assessment), Buprenorphine or Butorphanol for moderate-to-severe pain.

Prognosis

Cases with identified husbandry contributors and addressed husbandry plus appropriate antibiotic therapy generally do well. Cases where husbandry cannot be optimised, where there is concurrent advanced disease, or where the underlying lesion is fungal granuloma rather than bacterial pneumonia have substantially worse outcomes.

Recurrence within weeks of apparent recovery is a strong signal that either the husbandry has not been adequately addressed or the underlying pathology is fungal / mechanical / neoplastic rather than primary bacterial pneumonia. Re-image and re-evaluate rather than re-prescribe the same antibiotic course.

Common protocol mistakes

1. Antibiotic-first, husbandry-later. The recurring failure mode in mixed practice. Husbandry review comes alongside the antibiotic choice, not after the second relapse.
2. Empirical aminoglycoside without hydration. Predictable nephrotoxicity in a patient who is often subclinically dehydrated at presentation. Pre-load fluids.
3. Q24h dosing of a reptile q48–72h drug. Predictable nephrotoxicity and clinical disappointment. Use the reptile-specific interval.
4. Skipping imaging. Coelomic mass effect, effusion, foreign body — all manifest as "respiratory" presentations and all need imaging to identify.
5. No culture in the moderately stable patient. Empirical therapy without culture is acceptable in the unstable patient but is a missed opportunity in the stable patient where you have the time to do the workup properly.

Sources

• Mader's Reptile and Amphibian Medicine and Surgery (respiratory chapter)
• Carpenter's Exotic Animal Formulary, current edition
• BSAVA Manual of Reptiles
• Peer-reviewed reptile respiratory disease literature
• Bearded dragon-specific husbandry consensus literature

Each drug page above carries explicit evidence-level and citation metadata. Browse the bearded dragon formulary for the live, source-cited drug data for the species.

Disclaimer

This article is an informational reference for licensed veterinary professionals, technicians, and students. It does not constitute veterinary medical advice and is not a substitute for clinical judgement, current peer-reviewed literature, or the recommendation of an attending clinician. See the full dosage disclaimer.